Development of a robust and generalizable algorithm "gQuant" for accurate normalizer gene selection in qRT-PCR analysis.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
13 08 2024
13 08 2024
Historique:
received:
01
02
2024
accepted:
03
07
2024
medline:
14
8
2024
pubmed:
14
8
2024
entrez:
13
8
2024
Statut:
epublish
Résumé
The emergent role of nucleic acid-based biomarkers-microRNAs(miRNAs), long non-coding RNAs(lncRNAs), and messenger RNAs(mRNAs), is becoming increasingly prominent in disease diagnostics and risk assessment. qRT-PCR is the primary analytical method for quantitative measurement of biomarkers. Yet, the relative infancy of non-coding RNAs recognition as biomarkers poses a challenge due to the absence of a consensus on a universally accepted normalizer gene, an absolute requirement for accurate quantification. Current tools normalizer selection are fraught with statistical limitations and suboptimal graphical user interface for data visualisation. These deficiencies underscore the necessity for a balanced tool tailored to handle qRT-PCR datasets. Addressing the identified challenges, we have developed 'gQuant' tool crafted to address these limitations. We employed voting classifiers that combine predictions from multiple statistical methods. Tool's efficacy was validated through different available and in house data derived from urinary exosomal miRNAs datasets. Comparative analysis with existing tools revealed that their integrated methodologies could skew the ranking of normalizer genes, whereas 'gQuant' consistently yielded rankings characterised by lower standard-deviation, reduced covariance, and enhanced kernel density estimation values. Given 'gQuant's' promising performance, normalizer gene identification will be greatly improved, improving precision of gene expression quantification in a variety of research scenarios. The gQuant tool developed for this study is available for public use and can be accessed at [ https://github.com/ABHAYHBB/gQuant-Tool ]."
Identifiants
pubmed: 39138232
doi: 10.1038/s41598-024-66770-y
pii: 10.1038/s41598-024-66770-y
doi:
Substances chimiques
MicroRNAs
0
RNA, Messenger
0
RNA, Long Noncoding
0
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
18774Subventions
Organisme : Banaras Hindu University
ID : 6031-B-21966
Organisme : Banaras Hindu University
ID : 3254/31.02
Informations de copyright
© 2024. The Author(s).
Références
Ye, J., Xu, M., Tian, X., Cai, S. & Zeng, S. Research advances in the detection of miRNA. J. Pharm. Anal. 9, 217–226 (2019).
doi: 10.1016/j.jpha.2019.05.004
pubmed: 31452959
pmcid: 6702429
Harshitha, R. & Arunraj, D. R. Real-time quantitative PCR: A tool for absolute and relative quantification. Biochem. Mol. Biol. Educ. 49, 800–812 (2021).
doi: 10.1002/bmb.21552
pubmed: 34132460
Smith, T. A. D. et al. Selection of endogenous control genes for normalising gene expression data derived from formalin-fixed paraffin-embedded tumour tissue. Sci. Rep. 10, 17258 (2020).
doi: 10.1038/s41598-020-74380-7
pubmed: 33057113
pmcid: 7560892
Suzuki, T., Higgins, P. J. & Crawford, D. R. Control selection for RNA quantitation. Biotechniques 29, 332–337 (2000).
doi: 10.2144/00292rv02
pubmed: 10948434
Identification of miR-23a as a novel microRNA normalizer for relative quantification in human uterine cervical tissues | Experimental & Molecular Medicine. https://www.nature.com/articles/emm201139 .
Danese, E. et al. Reference miRNAs for colorectal cancer: analysis and verification of current data. Sci. Rep. 7, 8413 (2017).
doi: 10.1038/s41598-017-08784-3
pubmed: 28827728
pmcid: 5567181
Reference Genes for qPCR-Based miRNA Expression Profiling in 14 Human Tissues - PubMed. https://pubmed.ncbi.nlm.nih.gov/35354155/ .
Jacobsen, K. S. et al. Identification of valid reference genes for microRNA expression studies in a hepatitis B virus replicating liver cell line. BMC Res. Notes 9, 38 (2016).
doi: 10.1186/s13104-016-1848-2
pubmed: 26801621
pmcid: 4724106
Xie, F., Wang, J. & Zhang, B. RefFinder: a web-based tool for comprehensively analyzing and identifying reference genes. Funct. Integr. Genomics 23, 125 (2023).
doi: 10.1007/s10142-023-01055-7
pubmed: 37060478
Bhatia, A., Upadhyay, A. K. & Sharma, S. miRNAs are now starring in “No Time to Die: Overcoming the chemoresistance in cancer”. IUBMB Life 75, 238–256 (2023).
doi: 10.1002/iub.2652
pubmed: 35678612
Condrat, C. E. et al. miRNAs as biomarkers in disease: Latest findings regarding their role in diagnosis and prognosis. Cells 9, 276 (2020).
doi: 10.3390/cells9020276
pubmed: 31979244
pmcid: 7072450
Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment - PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152632/ .
Piao, X.-M., Cha, E.-J., Yun, S. J. & Kim, W.-J. Role of exosomal miRNA in bladder cancer: A promising liquid biopsy biomarker. Int. J. Mol. Sci. 22, 1713 (2021).
doi: 10.3390/ijms22041713
pubmed: 33567779
pmcid: 7915637
Mugoni, V., Ciani, Y., Nardella, C. & Demichelis, F. Circulating RNAs in prostate cancer patients. Cancer Lett. 524, 57–69 (2022).
doi: 10.1016/j.canlet.2021.10.011
pubmed: 34656688
Zidan, H. E., Abdul-Maksoud, R. S., Elsayed, W. S. H. & Desoky, E. A. M. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer. IUBMB Life 70, 437–444 (2018).
doi: 10.1002/iub.1733
pubmed: 29522280
Sewer, A. et al. Assessment of a novel multi-array normalization method based on spike-in control probes suitable for microRNA datasets with global decreases in expression. BMC Res. Notes 7, 302 (2014).
doi: 10.1186/1756-0500-7-302
pubmed: 24886675
pmcid: 4077261
Pagacz, K. et al. A systemic approach to screening high-throughput RT-qPCR data for a suitable set of reference circulating miRNAs. BMC Genom. 21, 111 (2020).
doi: 10.1186/s12864-020-6530-3
Lekchnov, E. A. et al. Searching for the novel specific predictors of prostate cancer in urine: The analysis of 84 miRNA expression. Int J Mol Sci 19, 4088 (2018).
doi: 10.3390/ijms19124088
pubmed: 30562989
pmcid: 6320807
Jain, G. et al. Urinary extracellular vesicles miRNA—A new era of prostate cancer biomarkers. Front Genet 14, 1065757 (2023).
doi: 10.3389/fgene.2023.1065757
pubmed: 36741322
pmcid: 9895092
Changes in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines | BMC Cancer | Full Text. https://bmccancer.biomedcentral.com/articles/ https://doi.org/10.1186/1471-2407-14-433 .
GEO Accession viewer. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE57888 .
Siddaiah, R. et al. MicroRNA signatures associated with bronchopulmonary dysplasia severity in tracheal aspirates of preterm infants. Biomedicines 9, 257 (2021).
doi: 10.3390/biomedicines9030257
pubmed: 33807742
pmcid: 8000397
GEO Accession viewer. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE239868 .
Bryzgunova, O. E. et al. Comparative study of extracellular vesicles from the urine of healthy individuals and prostate cancer patients. PLoS One 11, e0157566 (2016).
doi: 10.1371/journal.pone.0157566
pubmed: 27305142
pmcid: 4909321
Rodríguez, M. et al. Identification of non-invasive miRNAs biomarkers for prostate cancer by deep sequencing analysis of urinary exosomes. Mol. Cancer 16, 156 (2017).
doi: 10.1186/s12943-017-0726-4
pubmed: 28982366
pmcid: 5629793